VIM and Sepsis: To test this hypothesis, the current study was carried out in the following three stages: screening target proteins from patient blood samples and selecting vimentin as a target protein, validation of the vimentin in the clinical setting of sepsis, and in vitro experimental studies to explore the role of vimentin in regulating apoptosis of lymphocytes in response to endotoxin exposure.